nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ALB—chronic obstructive pulmonary disease	0.225	1	CbGaD
Dronedarone—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.139	0.251	CbGbCtD
Dronedarone—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.105	0.19	CbGbCtD
Dronedarone—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.105	0.19	CbGbCtD
Dronedarone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0267	0.0484	CbGbCtD
Dronedarone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0267	0.0484	CbGbCtD
Dronedarone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0238	0.0431	CbGbCtD
Dronedarone—ALB—Prednisone—chronic obstructive pulmonary disease	0.0228	0.0412	CbGbCtD
Dronedarone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0224	0.0406	CbGbCtD
Dronedarone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0151	0.0274	CbGbCtD
Dronedarone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0145	0.0262	CbGbCtD
Dronedarone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0129	0.0233	CbGbCtD
Dronedarone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0126	0.0228	CbGbCtD
Dronedarone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0119	0.0216	CbGbCtD
Dronedarone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00756	0.0137	CbGbCtD
Dronedarone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00714	0.0129	CbGbCtD
Dronedarone—Atrial flutter—Arformoterol—chronic obstructive pulmonary disease	0.00422	0.0335	CcSEcCtD
Dronedarone—Atrial flutter—Formoterol—chronic obstructive pulmonary disease	0.00422	0.0335	CcSEcCtD
Dronedarone—Traumatic liver injury—Montelukast—chronic obstructive pulmonary disease	0.00422	0.0335	CcSEcCtD
Dronedarone—Leukocytoclastic vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00321	0.0254	CcSEcCtD
Dronedarone—Dermatitis atopic—Montelukast—chronic obstructive pulmonary disease	0.00212	0.0168	CcSEcCtD
Dronedarone—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00187	0.0148	CcSEcCtD
Dronedarone—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00178	0.0141	CcSEcCtD
Dronedarone—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.0133	CcSEcCtD
Dronedarone—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00161	0.0128	CcSEcCtD
Dronedarone—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.0117	CcSEcCtD
Dronedarone—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.0114	CcSEcCtD
Dronedarone—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.0113	CcSEcCtD
Dronedarone—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.011	CcSEcCtD
Dronedarone—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.0107	CcSEcCtD
Dronedarone—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.0102	CcSEcCtD
Dronedarone—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.00128	0.0102	CcSEcCtD
Dronedarone—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00127	0.0101	CcSEcCtD
Dronedarone—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.01	CcSEcCtD
Dronedarone—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00971	CcSEcCtD
Dronedarone—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00931	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00927	CcSEcCtD
Dronedarone—Amiodarone—CYP1A1—chronic obstructive pulmonary disease	0.00111	0.509	CrCbGaD
Dronedarone—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.00877	CcSEcCtD
Dronedarone—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00869	CcSEcCtD
Dronedarone—Amiodarone—CYP1A2—chronic obstructive pulmonary disease	0.00107	0.491	CrCbGaD
Dronedarone—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00841	CcSEcCtD
Dronedarone—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00841	CcSEcCtD
Dronedarone—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00794	CcSEcCtD
Dronedarone—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000993	0.00787	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000974	0.00772	CcSEcCtD
Dronedarone—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000973	0.00771	CcSEcCtD
Dronedarone—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000923	0.00731	CcSEcCtD
Dronedarone—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000906	0.00718	CcSEcCtD
Dronedarone—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000902	0.00715	CcSEcCtD
Dronedarone—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0009	0.00714	CcSEcCtD
Dronedarone—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000892	0.00707	CcSEcCtD
Dronedarone—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.000891	0.00706	CcSEcCtD
Dronedarone—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000885	0.00701	CcSEcCtD
Dronedarone—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.000853	0.00677	CcSEcCtD
Dronedarone—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000832	0.00659	CcSEcCtD
Dronedarone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00081	0.00642	CcSEcCtD
Dronedarone—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000795	0.0063	CcSEcCtD
Dronedarone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000772	0.00612	CcSEcCtD
Dronedarone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000753	0.00597	CcSEcCtD
Dronedarone—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000748	0.00593	CcSEcCtD
Dronedarone—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000748	0.00593	CcSEcCtD
Dronedarone—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000738	0.00585	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00583	CcSEcCtD
Dronedarone—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000733	0.00581	CcSEcCtD
Dronedarone—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000728	0.00577	CcSEcCtD
Dronedarone—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000728	0.00577	CcSEcCtD
Dronedarone—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000727	0.00576	CcSEcCtD
Dronedarone—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.00576	CcSEcCtD
Dronedarone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000717	0.00569	CcSEcCtD
Dronedarone—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000713	0.00565	CcSEcCtD
Dronedarone—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000712	0.00564	CcSEcCtD
Dronedarone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000711	0.00564	CcSEcCtD
Dronedarone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000711	0.00563	CcSEcCtD
Dronedarone—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.0056	CcSEcCtD
Dronedarone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000696	0.00552	CcSEcCtD
Dronedarone—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000696	0.00552	CcSEcCtD
Dronedarone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00547	CcSEcCtD
Dronedarone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000689	0.00546	CcSEcCtD
Dronedarone—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000688	0.00545	CcSEcCtD
Dronedarone—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000687	0.00545	CcSEcCtD
Dronedarone—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000687	0.00545	CcSEcCtD
Dronedarone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00544	CcSEcCtD
Dronedarone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00067	0.00531	CcSEcCtD
Dronedarone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000662	0.00525	CcSEcCtD
Dronedarone—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00514	CcSEcCtD
Dronedarone—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000647	0.00513	CcSEcCtD
Dronedarone—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00508	CcSEcCtD
Dronedarone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00508	CcSEcCtD
Dronedarone—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000628	0.00498	CcSEcCtD
Dronedarone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000625	0.00495	CcSEcCtD
Dronedarone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000615	0.00488	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000613	0.00486	CcSEcCtD
Dronedarone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000605	0.0048	CcSEcCtD
Dronedarone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000595	0.00472	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.0047	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000593	0.0047	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00461	CcSEcCtD
Dronedarone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00058	0.0046	CcSEcCtD
Dronedarone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.00454	CcSEcCtD
Dronedarone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000573	0.00454	CcSEcCtD
Dronedarone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.00445	CcSEcCtD
Dronedarone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000562	0.00445	CcSEcCtD
Dronedarone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000561	0.00445	CcSEcCtD
Dronedarone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000561	0.00445	CcSEcCtD
Dronedarone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00441	CcSEcCtD
Dronedarone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00441	CcSEcCtD
Dronedarone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00436	CcSEcCtD
Dronedarone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000545	0.00432	CcSEcCtD
Dronedarone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00429	CcSEcCtD
Dronedarone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000532	0.00422	CcSEcCtD
Dronedarone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00053	0.0042	CcSEcCtD
Dronedarone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00416	CcSEcCtD
Dronedarone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000515	0.00408	CcSEcCtD
Dronedarone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000506	0.00401	CcSEcCtD
Dronedarone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000504	0.004	CcSEcCtD
Dronedarone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.004	CcSEcCtD
Dronedarone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.00398	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.00392	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000494	0.00392	CcSEcCtD
Dronedarone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00391	CcSEcCtD
Dronedarone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.00391	CcSEcCtD
Dronedarone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000494	0.00391	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000484	0.00384	CcSEcCtD
Dronedarone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000484	0.00383	CcSEcCtD
Dronedarone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000478	0.00379	CcSEcCtD
Dronedarone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.00377	CcSEcCtD
Dronedarone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000474	0.00376	CcSEcCtD
Dronedarone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000474	0.00376	CcSEcCtD
Dronedarone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00047	0.00372	CcSEcCtD
Dronedarone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00371	CcSEcCtD
Dronedarone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00371	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.0037	CcSEcCtD
Dronedarone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000466	0.0037	CcSEcCtD
Dronedarone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000459	0.00364	CcSEcCtD
Dronedarone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00359	CcSEcCtD
Dronedarone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00359	CcSEcCtD
Dronedarone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.00358	CcSEcCtD
Dronedarone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00355	CcSEcCtD
Dronedarone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00354	CcSEcCtD
Dronedarone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00354	CcSEcCtD
Dronedarone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000444	0.00352	CcSEcCtD
Dronedarone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00352	CcSEcCtD
Dronedarone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.00351	CcSEcCtD
Dronedarone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00339	CcSEcCtD
Dronedarone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000422	0.00334	CcSEcCtD
Dronedarone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00331	CcSEcCtD
Dronedarone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00326	CcSEcCtD
Dronedarone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00326	CcSEcCtD
Dronedarone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00321	CcSEcCtD
Dronedarone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00321	CcSEcCtD
Dronedarone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00319	CcSEcCtD
Dronedarone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00315	CcSEcCtD
Dronedarone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00311	CcSEcCtD
Dronedarone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00311	CcSEcCtD
Dronedarone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00308	CcSEcCtD
Dronedarone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00304	CcSEcCtD
Dronedarone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00303	CcSEcCtD
Dronedarone—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00038	0.00301	CcSEcCtD
Dronedarone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00293	CcSEcCtD
Dronedarone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00289	CcSEcCtD
Dronedarone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00289	CcSEcCtD
Dronedarone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00286	CcSEcCtD
Dronedarone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00286	CcSEcCtD
Dronedarone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00286	CcSEcCtD
Dronedarone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00286	CcSEcCtD
Dronedarone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00283	CcSEcCtD
Dronedarone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000354	0.0028	CcSEcCtD
Dronedarone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000353	0.0028	CcSEcCtD
Dronedarone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.00275	CcSEcCtD
Dronedarone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00273	CcSEcCtD
Dronedarone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.0027	CcSEcCtD
Dronedarone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.0027	CcSEcCtD
Dronedarone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00034	0.0027	CcSEcCtD
Dronedarone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.0027	CcSEcCtD
Dronedarone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00264	CcSEcCtD
Dronedarone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000323	0.00256	CcSEcCtD
Dronedarone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00255	CcSEcCtD
Dronedarone—CACNB3—bronchus—chronic obstructive pulmonary disease	0.000312	0.0999	CbGeAlD
Dronedarone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.00246	CcSEcCtD
Dronedarone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00228	CcSEcCtD
Dronedarone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00227	CcSEcCtD
Dronedarone—CACNB3—trachea—chronic obstructive pulmonary disease	0.00028	0.0897	CbGeAlD
Dronedarone—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00219	CcSEcCtD
Dronedarone—CACNB4—lung—chronic obstructive pulmonary disease	0.000263	0.0842	CbGeAlD
Dronedarone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000252	0.002	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00185	CcSEcCtD
Dronedarone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00179	CcSEcCtD
Dronedarone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00175	CcSEcCtD
Dronedarone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00174	CcSEcCtD
Dronedarone—CACNA1C—respiratory system—chronic obstructive pulmonary disease	0.000205	0.0658	CbGeAlD
Dronedarone—CACNB3—lung—chronic obstructive pulmonary disease	0.000201	0.0645	CbGeAlD
Dronedarone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00157	CcSEcCtD
Dronedarone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00155	CcSEcCtD
Dronedarone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00155	CcSEcCtD
Dronedarone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00154	CcSEcCtD
Dronedarone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00146	CcSEcCtD
Dronedarone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00146	CcSEcCtD
Dronedarone—CACNA1C—connective tissue—chronic obstructive pulmonary disease	0.000181	0.0579	CbGeAlD
Dronedarone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00141	CcSEcCtD
Dronedarone—CACNA1C—smooth muscle tissue—chronic obstructive pulmonary disease	0.000165	0.053	CbGeAlD
Dronedarone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00128	CcSEcCtD
Dronedarone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00126	CcSEcCtD
Dronedarone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00122	CcSEcCtD
Dronedarone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00114	CcSEcCtD
Dronedarone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00113	CcSEcCtD
Dronedarone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00113	CcSEcCtD
Dronedarone—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000141	0.0452	CbGeAlD
Dronedarone—CACNB2—lung—chronic obstructive pulmonary disease	0.000135	0.0433	CbGeAlD
Dronedarone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00106	CcSEcCtD
Dronedarone—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000132	0.0423	CbGeAlD
Dronedarone—SCN1A—lung—chronic obstructive pulmonary disease	0.000131	0.0421	CbGeAlD
Dronedarone—CACNA1D—lung—chronic obstructive pulmonary disease	0.000118	0.0379	CbGeAlD
Dronedarone—CACNA1C—lung—chronic obstructive pulmonary disease	0.000109	0.0349	CbGeAlD
Dronedarone—ADRA2C—bronchus—chronic obstructive pulmonary disease	9.94e-05	0.0318	CbGeAlD
Dronedarone—ADRA2C—trachea—chronic obstructive pulmonary disease	8.92e-05	0.0286	CbGeAlD
Dronedarone—ADRB1—lung—chronic obstructive pulmonary disease	8.51e-05	0.0273	CbGeAlD
Dronedarone—ADRA2A—connective tissue—chronic obstructive pulmonary disease	8.48e-05	0.0272	CbGeAlD
Dronedarone—ADRA2A—bronchus—chronic obstructive pulmonary disease	7.93e-05	0.0254	CbGeAlD
Dronedarone—ADRA2A—trachea—chronic obstructive pulmonary disease	7.12e-05	0.0228	CbGeAlD
Dronedarone—ADRA2C—lung—chronic obstructive pulmonary disease	6.41e-05	0.0205	CbGeAlD
Dronedarone—ABCB1—respiratory system—chronic obstructive pulmonary disease	5.37e-05	0.0172	CbGeAlD
Dronedarone—ADRA2A—lung—chronic obstructive pulmonary disease	5.11e-05	0.0164	CbGeAlD
Dronedarone—ABCB1—trachea—chronic obstructive pulmonary disease	3.97e-05	0.0127	CbGeAlD
Dronedarone—ABCB1—lung—chronic obstructive pulmonary disease	2.85e-05	0.00913	CbGeAlD
Dronedarone—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.71e-05	0.000188	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.71e-05	0.000188	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.71e-05	0.000188	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.68e-05	0.000185	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.68e-05	0.000185	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.68e-05	0.000184	CbGpPWpGaD
Dronedarone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.67e-05	0.000184	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.66e-05	0.000183	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000183	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—ALB—chronic obstructive pulmonary disease	1.66e-05	0.000182	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.66e-05	0.000182	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.65e-05	0.000182	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.65e-05	0.000181	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	1.64e-05	0.000181	CbGpPWpGaD
Dronedarone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.64e-05	0.00018	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.63e-05	0.000179	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.62e-05	0.000178	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	1.6e-05	0.000176	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.59e-05	0.000175	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.000175	CbGpPWpGaD
Dronedarone—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.59e-05	0.000175	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.59e-05	0.000174	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.57e-05	0.000173	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	0.000173	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.000172	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.57e-05	0.000172	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.56e-05	0.000171	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000171	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.55e-05	0.00017	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.54e-05	0.00017	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.54e-05	0.000169	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.000169	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.52e-05	0.000167	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.5e-05	0.000165	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000165	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.49e-05	0.000164	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.48e-05	0.000163	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	1.46e-05	0.000161	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.46e-05	0.000161	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.43e-05	0.000157	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.43e-05	0.000157	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.41e-05	0.000155	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.4e-05	0.000154	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.4e-05	0.000154	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.39e-05	0.000153	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.000153	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.000152	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.38e-05	0.000152	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000152	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.37e-05	0.000151	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.00015	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.35e-05	0.000148	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000145	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.31e-05	0.000144	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.3e-05	0.000143	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.3e-05	0.000143	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.3e-05	0.000143	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.29e-05	0.000142	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.29e-05	0.000142	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.29e-05	0.000142	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.000141	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.28e-05	0.000141	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.000141	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.28e-05	0.000141	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.28e-05	0.00014	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.00014	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.000139	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.27e-05	0.000139	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000136	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.23e-05	0.000135	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000133	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.2e-05	0.000132	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.19e-05	0.00013	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.18e-05	0.000129	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000129	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000128	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.16e-05	0.000128	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.000128	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.16e-05	0.000128	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000127	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.15e-05	0.000127	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.14e-05	0.000125	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.14e-05	0.000125	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.13e-05	0.000124	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	1.13e-05	0.000124	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.12e-05	0.000124	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000123	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.12e-05	0.000123	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.11e-05	0.000122	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000122	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000119	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.08e-05	0.000118	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.000117	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.06e-05	0.000117	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000117	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.06e-05	0.000117	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.000116	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000116	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.06e-05	0.000116	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.000116	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	1.05e-05	0.000116	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000116	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.05e-05	0.000115	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000115	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.04e-05	0.000114	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.04e-05	0.000114	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.03e-05	0.000114	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.02e-05	0.000112	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000111	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.01e-05	0.000111	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.85e-06	0.000108	CbGpPWpGaD
Dronedarone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.83e-06	0.000108	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.8e-06	0.000108	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.78e-06	0.000108	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.78e-06	0.000108	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.69e-06	0.000107	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.63e-06	0.000106	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.54e-06	0.000105	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.48e-06	0.000104	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.46e-06	0.000104	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.42e-06	0.000104	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.41e-06	0.000103	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.37e-06	0.000103	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.32e-06	0.000103	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.27e-06	0.000102	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.93e-06	9.82e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.88e-06	9.76e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.81e-06	9.68e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.79e-06	9.66e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.75e-06	9.63e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.75e-06	9.63e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.74e-06	9.61e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.62e-06	9.47e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.61e-06	9.47e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	8.55e-06	9.4e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.55e-06	9.4e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.54e-06	9.38e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.23e-06	9.05e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.2e-06	9.02e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	8.2e-06	9.02e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.16e-06	8.97e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.15e-06	8.96e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8e-06	8.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.95e-06	8.74e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	7.84e-06	8.62e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.78e-06	8.55e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.78e-06	8.55e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.78e-06	8.55e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.73e-06	8.5e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.71e-06	8.47e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.67e-06	8.43e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.65e-06	8.41e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.65e-06	8.41e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.42e-06	8.16e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.35e-06	8.09e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.33e-06	8.06e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.23e-06	7.95e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.2e-06	7.91e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.15e-06	7.86e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.11e-06	7.82e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.09e-06	7.79e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.08e-06	7.79e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.02e-06	7.72e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.91e-06	7.6e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.9e-06	7.58e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.87e-06	7.55e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.83e-06	7.51e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.78e-06	7.45e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.76e-06	7.43e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	6.75e-06	7.42e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.73e-06	7.41e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	6.66e-06	7.32e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.56e-06	7.21e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.56e-06	7.21e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.45e-06	7.1e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.38e-06	7.02e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	6.37e-06	7e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.29e-06	6.92e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.29e-06	6.91e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.24e-06	6.86e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.24e-06	6.86e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.23e-06	6.85e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.01e-06	6.6e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.98e-06	6.57e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.92e-06	6.51e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.85e-06	6.43e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.82e-06	6.4e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.75e-06	6.32e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.73e-06	6.3e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.73e-06	6.3e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.69e-06	6.25e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.63e-06	6.19e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.6e-06	6.16e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.58e-06	6.13e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.53e-06	6.08e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.44e-06	5.99e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.33e-06	5.86e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.26e-06	5.79e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.18e-06	5.69e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.14e-06	5.65e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.11e-06	5.61e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.09e-06	5.59e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.06e-06	5.56e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.04e-06	5.54e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	5.03e-06	5.53e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.84e-06	5.32e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.79e-06	5.27e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.73e-06	5.2e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.73e-06	5.2e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.72e-06	5.2e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.69e-06	5.15e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.65e-06	5.11e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.64e-06	5.1e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.61e-06	5.06e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.6e-06	5.06e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.59e-06	5.05e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.55e-06	5.01e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.49e-06	4.94e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.41e-06	4.84e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.4e-06	4.84e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.34e-06	4.77e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.34e-06	4.77e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.27e-06	4.7e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.27e-06	4.69e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.25e-06	4.68e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.23e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.18e-06	4.6e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.17e-06	4.59e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.15e-06	4.56e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.13e-06	4.54e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.88e-06	4.26e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.86e-06	4.24e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.84e-06	4.22e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.82e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.79e-06	4.17e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.72e-06	4.09e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.57e-06	3.93e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.53e-06	3.88e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.52e-06	3.87e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.51e-06	3.86e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.5e-06	3.85e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.45e-06	3.8e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.27e-06	3.59e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.22e-06	3.54e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.12e-06	3.43e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.9e-06	3.19e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.86e-06	3.14e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.84e-06	3.12e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.71e-06	2.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.65e-06	2.92e-05	CbGpPWpGaD
